We invite you to submit research proposals to the SHIONOGI Science Program, an international collaboration call for drug discovery. The collaboration research budget will be a maximum of JPY 15 million per year per project for up to three years.
Shionogi has a strong track record in productivity in drug discovery. They generate more than 60% of the development products in their pipeline. The products they are developing include candidate drugs originating from the Shionogi Research Laboratories, those from external seeds, and products derived from collaborative research with academic scientists and biopharmaceutical companies. Their strength is that they do not rely solely on in-house development, and develop drugs that incorporate a wide variety of ideas.
The SHIONOGI Science Program will be open for scientists who are based in Australia, Belgium, Denmark, France, Germany, Ireland, Italy, Luxembourg, New Zealand, the Netherlands, and the UK. The application areas for this year are infectious diseases, CNS and pain research.
Proposal submissions for primary selection:
Primary selection results sent by:
Proposal submissions for secondary (final) selection:
Final decision notified by:
For any questions specific to the SHIONOGI Science Program, please contact SHIONOGI Science Program Team at [email protected]